Reliant AI
AI NativeAI-Powered Research for the Life Sciences
Est 2023|Raised $13.5M
Published Jul 14, 2026
| Starting Price | Not publicly listed (demo / sales-led) | Quote-based (enterprise) | Quote-based (enterprise) |
| Primary Use Cases | AI-assisted extraction and source-linked verification for evidence workflows | Drug/pipeline/competitive intelligence with extensive curated datasets | Trial/pipeline/market intelligence with monitoring and standard datasets |
| Noted Strengths | Workflow for structured extraction and source verification; extraction-to-export pipeline | Breadth of curated life-sciences data and enterprise adoption | Deep trial intelligence and monitoring capabilities; industry-standard datasets |
| Noted Weaknesses | Limited independent public reviews; unclear public security certifications; SSO documented as forthcoming | Cost and integration complexity for bespoke extraction workflows | Cost and procurement overhead; may require add-ons for bespoke extraction workflows |
—